3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
NCT00159744
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
488
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Disorder
Interventions
DRUG:
Asenapine
DRUG:
Olanzapine
DRUG:
Placebo
Sponsor
Organon and Co
Collaborators
[object Object]